RxDoctor Payments Data

Alison Green, MD

Family Medicine · Newport, ARNPI 1508157371

Payments from drug & device makers

$783in general payments, 2019–2025

Across 41 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$259
  • Abbott$143
  • Astellas Pharma US Inc$100
  • GSK$85
  • Amgen$31
  • Novo Nordisk$30
  • plus $134 from 8 others

What the payments were for

  • Food & beverage$68387%
  • Education$10013%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$783 in reported general payments places this provider in the 55th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$72,769
Medicare patients
207
Services billed
1,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$116,207
EliquisApixaban69$56,810
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$39,118
MounjaroTirzepatide33$35,637
RybelsusSemaglutide24$33,931
XareltoRivaroxaban50$32,880
JardianceEmpagliflozin40$32,250
FarxigaDapagliflozin Propanediol34$27,822
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$17,609
Tresiba Flextouch U-100Insulin Degludec22$15,957
LinzessLinaclotide18$11,391
Praluent PenAlirocumab17$9,835
Spiriva RespimatTiotropium Bromide13$7,972
Incruse ElliptaUmeclidinium Bromide15$6,489
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$5,838

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Levemir$30$151,971143 claims
PfizerEliquis$18$56,81069 claims
GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta$85$50,91470 claims
Lilly USA, LLCMounjaro$15$35,63733 claims
AbbVieLinzess, Synthroid$259$12,92849 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Newport

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →